{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:02:40Z","timestamp":1790226160807,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04344-2","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:57:11Z","timestamp":1759406231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oral and fecal microbiome alterations in pancreatic cancer: insights into potential diagnostic biomarkers"],"prefix":"10.1186","volume":"25","author":[{"given":"Sogol","family":"Tavanaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Feizabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvenaz","family":"Falsafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Asadzadeh","family":"Aghdaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"1","key":"4344_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41416-023-02488-4","volume":"130","author":"W Shi","year":"2024","unstructured":"Shi W, Wartmann T, Accuffi S, Al-Madhi S, Perrakis A, Kahlert C, et al. Integrating a MicroRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. Br J Cancer. 2024;130(1):125\u201334.","journal-title":"Br J Cancer"},{"issue":"3","key":"4344_CR2","first-page":"332","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shi S, Zhang B, Ni Q, Yu X, Xu J. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes. Am J Cancer Res. 2018;8(3):332.","journal-title":"Am J Cancer Res"},{"key":"4344_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102655","author":"W Yao","year":"2020","unstructured":"Yao W, Maitra A, Ying H. Recent insights into the biology of pancreatic cancer. EBioMedicine. 2020. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102655.","journal-title":"EBioMedicine"},{"key":"4344_CR4","doi-asserted-by":"crossref","unstructured":"Hesami Z, Olfatifar M, Sadeghi A, Zali Mohammad R, Mohammadi-Yeganeh S, Habibi Mohammad A et al. Global trend in pancreatic cancer prevalence rates through 2040: an Illness-Death modeling study. Cancer Med. 2024;13(20):e70318.","DOI":"10.1002\/cam4.70318"},{"key":"4344_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00235-7","author":"T Pollini","year":"2022","unstructured":"Pollini T, Adsay V, Capurso G, Dal Molin M, Esposito I, Hruban R, et al. The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. Lancet Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1016\/S2468-1253(22)00235-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4344_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.02.023","author":"Y Nodari","year":"2023","unstructured":"Nodari Y, Gentiluomo M, Mohelnikova-Duchonova B, Kreivenaite E, Milanetto AC, Skieceviciene J, et al. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Dig Liver Dis. 2023. https:\/\/doi.org\/10.1016\/j.dld.2023.02.023.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"4344_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.31557\/apjcb.2024.9.1.61-66","volume":"9","author":"D Mahajan","year":"2024","unstructured":"Mahajan D, kumar Pandey A. Pancreatic carcinoma: exploring its relationship with diabetes and the potential chemopreventive effects of Metformin. Asian Pac J Cancer Biology. 2024;9(1):61\u20136.","journal-title":"Asian Pac J Cancer Biology"},{"issue":"14","key":"4344_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143634","volume":"15","author":"O Partyka","year":"2023","unstructured":"Partyka O, Pajewska M, Kwa\u015bniewska D, Czerw A, Depta\u0142a A, Budzik M, et al. Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations. Cancers. 2023;15(14):3634.","journal-title":"Cancers"},{"key":"4344_CR9","unstructured":"Molinari M, Liu H, Kaltenmeier C. Epidemiology and Risk Factors of Pancreatic Cancer. Acta Biomed. 2018;89(9):141\u2013146."},{"key":"4344_CR10","doi-asserted-by":"crossref","unstructured":"Placido D, Yuan B, Hjaltelin JX, Zheng C, Haue AD, Chmura PJ et al. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023;29(5):1\u201310.","DOI":"10.1038\/s41591-023-02332-5"},{"issue":"1","key":"4344_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4344_CR12","first-page":"150","volume":"10","author":"S Rezasoltani","year":"2017","unstructured":"Rezasoltani S, Nazemalhosseini Mojarrad E, Norouzinia M, Asadzadeh Aghdaei H. The necessity of gut microbiome characterization in diseases prevention and therapy. Gastroenterol Hepatol Bed Bench. 2017;10(2):150\u20131.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"4344_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216031","volume":"554","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Zhang W, Zhang Z, Sha G, Wang D, Tang D. Intratumoral microbiota: a new force in diagnosing and treating pancreatic cancer. Cancer Lett. 2023;554:216031.","journal-title":"Cancer Lett"},{"issue":"1","key":"4344_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15171\/mejdd.2020.157","volume":"12","author":"S Rezasoltani","year":"2020","unstructured":"Rezasoltani S, Ahmadi Bashirzadeh D, Nazemalhosseini Mojarad E, Asadzadeh Aghdaei H, Norouzinia M, Shahrokh S. Signature of gut microbiome by conventional and advanced analysis techniques: advantages and disadvantages. Middle East J Dig Dis. 2020;12(1):5\u201311.","journal-title":"Middle East J Dig Dis"},{"issue":"1","key":"4344_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41575-019-0242-7","volume":"17","author":"RM Thomas","year":"2020","unstructured":"Thomas RM, Jobin C. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol. 2020;17(1):53\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"4344_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10555-021-09982-2","volume":"40","author":"JJ Li","year":"2021","unstructured":"Li JJ, Zhu M, Kashyap PC, Chia N, Tran NH, McWilliams RR, et al. The role of microbiome in pancreatic cancer. Cancer Metastasis Rev. 2021;40(3):777\u201389.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"4344_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, Rodr\u00edguez-Perales S, Wirbel J, Maistrenko OM, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71(7):1359\u201372.","journal-title":"Gut"},{"key":"4344_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/03936155231166721","author":"T Chen","year":"2023","unstructured":"Chen T, Li X, Li G, Liu Y, Huang X, Ma W, et al. Alterations of commensal microbiota are associated with pancreatic cancer. Int J Biol Markers. 2023. https:\/\/doi.org\/10.1177\/03936155231166721.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"4344_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","volume":"67","author":"X Fan","year":"2018","unstructured":"Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67(1):120\u20137.","journal-title":"Gut"},{"issue":"12","key":"4344_CR20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41416-022-02018-8","volume":"127","author":"J Yu","year":"2022","unstructured":"Yu J, Ploner A, Chen MS, Zhang J, Sandborgh-Englund G, Ye W. Poor dental health and risk of pancreatic cancer: a nationwide registry-based cohort study in Sweden, 2009\u20132016. Br J Cancer. 2022;127(12):2133\u201340.","journal-title":"Br J Cancer"},{"issue":"3","key":"4344_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.gtc.2019.04.008","volume":"48","author":"TM Karpi\u0144ski","year":"2019","unstructured":"Karpi\u0144ski TM. The microbiota and pancreatic cancer. Gastroenterol Clin North Am. 2019;48(3):447\u201364.","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"4344_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.7150\/jca.52943","volume":"13","author":"X Guo","year":"2022","unstructured":"Guo X, Hu Z, Rong S, Xie G, Nie G, Liu X, et al. Integrative analysis of metabolome and gut microbiota in patients with pancreatic ductal adenocarcinoma. J Cancer. 2022;13(5):1555.","journal-title":"J Cancer"},{"issue":"2","key":"4344_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biom14020210","volume":"14","author":"B Chen","year":"2024","unstructured":"Chen B, Patel S, Bao L, Nadeem D, Krittanawong C. Pro-inflammatory food, gut microbiota, and cardiovascular and pancreatic diseases. Biomolecules. 2024;14(2):210.","journal-title":"Biomolecules"},{"key":"4344_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40200-020-00502-7","volume":"19","author":"H-S Ejtahed","year":"2020","unstructured":"Ejtahed H-S, Hoseini-Tavassol Z, Khatami S, Zangeneh M, Behrouzi A, Ahmadi Badi S, et al. Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults. J Diabetes Metab Disord. 2020;19:265\u201371.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"4344_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03534-8","volume":"24","author":"N Soveid","year":"2024","unstructured":"Soveid N, Barkhidarian B, Samadi M, Hatami M, Gholami F, Yekaninejad MS, et al. Animal and plant protein intake association with mental health, tryptophan metabolites pathways, and gut microbiota in healthy women: a cross-sectional study. BMC Microbiol. 2024;24(1):390.","journal-title":"BMC Microbiol"},{"issue":"1","key":"4344_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-56","volume":"12","author":"CM Liu","year":"2012","unstructured":"Liu CM, Aziz M, Kachur S, Hsueh P-R, Huang Y-T, Keim P, et al. Bactquant: an enhanced broad-coverage bacterial quantitative real-time PCR assay. BMC Microbiol. 2012;12(1):56.","journal-title":"BMC Microbiol"},{"issue":"6","key":"4344_CR27","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1128\/JCM.42.6.2566-2572.2004","volume":"42","author":"SJ Ott","year":"2004","unstructured":"Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol. 2004;42(6):2566\u201372.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4344_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","volume":"61","author":"JJ Farrell","year":"2012","unstructured":"Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61(4):582\u20138.","journal-title":"Gut"},{"issue":"8","key":"4344_CR29","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-16-1599","volume":"23","author":"Q Liang","year":"2017","unstructured":"Liang Q, Chiu J, Chen Y, Huang Y, Higashimori A, Fang J, et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin Cancer Res. 2017;23(8):2061\u201370.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4344_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/AEM.70.1.167-173.2004","volume":"70","author":"T Matsuki","year":"2004","unstructured":"Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K, et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004;70(1):167\u201373.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"4344_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/03936155231166721","volume":"38","author":"T Chen","year":"2023","unstructured":"Chen T, Li X, Li G, Liu Y, Huang X, Ma W, et al. Alterations of commensal microbiota are associated with pancreatic cancer. Int J Biol Markers. 2023;38(2):89\u201398.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"4344_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1983101","volume":"13","author":"A Halimi","year":"2021","unstructured":"Halimi A, Gabarrini G, Sobkowiak MJ, Ateeb Z, Davanian H, Gaiser RA, et al. Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties. Gut Microbes. 2021;13(1):1983101.","journal-title":"Gut Microbes"},{"issue":"12","key":"4344_CR33","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1136\/gutjnl-2018-317458","volume":"68","author":"RA Gaiser","year":"2019","unstructured":"Gaiser RA, Halimi A, Alkharaan H, Lu L, Davanian H, Healy K, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019;68(12):2186\u201394.","journal-title":"Gut"},{"issue":"48","key":"4344_CR34","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.3748\/wjg.v26.i48.7679","volume":"26","author":"A-L Wei","year":"2020","unstructured":"Wei A-L, Li M, Li G-Q, Wang X, Hu W-M, Li Z-L, et al. Oral microbiome and pancreatic cancer. World J Gastroenterol. 2020;26(48):7679.","journal-title":"World J Gastroenterol"},{"key":"4344_CR35","doi-asserted-by":"crossref","unstructured":"Wang X-Y, Sun Z-X, Makale EC, Sun Z-K, Wang T-C, Hou Z-Y et al. Gut microbial profile in patients with pancreatic cancer. Jundishapur J Microbiol. 2022;15(4):e122386.","DOI":"10.5812\/jjm-122386"},{"issue":"56","key":"4344_CR36","doi-asserted-by":"publisher","first-page":"95176","DOI":"10.18632\/oncotarget.18820","volume":"8","author":"Z Ren","year":"2017","unstructured":"Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, et al. Gut microbial profile analysis by miseq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8(56):95176.","journal-title":"Oncotarget"},{"issue":"10","key":"4344_CR37","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1016\/j.apsb.2023.08.002","volume":"13","author":"L-L Pan","year":"2023","unstructured":"Pan L-L, Ren Z-N, Yang J, Li B-B, Huang Y-W, Song D-X, et al. Gut microbiota controls the development of chronic pancreatitis: a critical role of short-chain fatty acids-producing gram-positive bacteria. Acta Pharm Sin B. 2023;13(10):4202\u201316.","journal-title":"Acta Pharm Sin B"},{"key":"4344_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001724","author":"J Hong","year":"2024","unstructured":"Hong J, Fu Y, Chen X, Zhang Y, Li X, Li T, et al. Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis. Int J Surg. 2024. https:\/\/doi.org\/10.1097\/JS9.0000000000001724.","journal-title":"Int J Surg"},{"issue":"9","key":"4344_CR39","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","volume":"6","author":"K Mitsuhashi","year":"2015","unstructured":"Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209.","journal-title":"Oncotarget"},{"issue":"9","key":"4344_CR40","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/cas.15901","volume":"114","author":"M Hayashi","year":"2023","unstructured":"Hayashi M, Ikenaga N, Nakata K, Luo H, Zhong P, Date S, et al. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 2023;114(9):3666\u201378.","journal-title":"Cancer Sci"},{"key":"4344_CR41","doi-asserted-by":"crossref","unstructured":"eBioMedicine. Emerging biomarkers for early diagnosis of pancreatic cancer. eBioMedicine. 2022;79:104064.","DOI":"10.1016\/j.ebiom.2022.104064"},{"issue":"5","key":"4344_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112314","volume":"28","author":"Z Hesami","year":"2025","unstructured":"Hesami Z, Sabzehali F, Khorsand B, Alipour S, Sadeghi A, Asri N, et al. Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: a comprehensive systematic review. iScience. 2025;28(5):112314.","journal-title":"iScience"},{"issue":"5","key":"4344_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.21037\/hbsn-22-380","volume":"11","author":"RC Wheatley","year":"2022","unstructured":"Wheatley RC, Valle JW, McNamara MG. The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC). Hepatobiliary Surg Nutr. 2022;11(5):752\u20134.","journal-title":"Hepatobiliary Surg Nutr"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04344-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:57:14Z","timestamp":1759406234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4344"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04344-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research Ethics Committees of Islamic Azad Tehran Medical Sciences University - Pharmacy and Pharmaceutical Branches Faculty (No. IR.IAU.PS.REC.1402.369).\u00a0This study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants before they were enrolled in the study. Ethical approval for this study was obtained from the Research Ethics Committees of Islamic Azad Tehran Medical Sciences University - Pharmacy and Pharmaceutical Branches Faculty (No. IR.IAU.PS.REC.1402.369) and all processes followed ethical guidelines. Participants were assured of the confidentiality of their data, which was anonymized for analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"624"}}